UNSPSC 12361500: Narcotic drug precursors

Includes component elements of substances whose ultimate effect upon the animal system is to produce torpor and insensibility; but taken in small quantities they at first exhilarate.

UNSPSC 12361500 Narcotic drug precursors is a Class code encompassing emergency medical and opioid-response pharmaceuticals, particularly naloxone, narcan, and controlled substances for emergency medical services deployment. State and local governments buy these products primarily through police departments, fire departments, emergency medical services agencies, and public health authorities for front-line overdose response, emergency care, and community health initiatives. Recent solicitations show demand for naloxone distribution programs, BLS and ALS pharmaceutical supplies for EMS transport and treatment, and drug deactivation systems alongside pharmacy management services. Issuing bodies include city police and fire departments, county EMS and health agencies, and state-supported higher-education institutions; no single repeat buyer dominates, though the City of Detroit appears twice in recent notices (prescription drug supplies for police and separate medical supplies for vending machines).

Activity concentrates in the Southeast and Southwest. The University of Georgia issued an RFQ for naloxone purchase and delivery due September 11, 2026; Forsyth County, Georgia posted an ITQ for pharmaceutical supplies as needed for 2027 with quotes due October 22, 2026; Seminole County, Florida sought 1,900 units of naloxone and 800 drug deactivation systems annually through IFB; and the City of Tucson Fire Department issued an RFP for BLS and ALS pharmaceuticals, supplies, and vending machines due June 24, 2026, federally funded through ARPA, HUD, and FTA with prevailing wage and DBE participation requirements. Williamson County, Texas issued IFB 26IFB63 for EMS medical and pharmaceutical items due August 4, 2026. The City of Detroit Office of Contracting and Procurement posted RFQ 551210 for prescription drug supplies with an amendment and response date October 9, 2026, applying equalization credits for certified Detroit-based and small businesses at 1 to 5 percent, and requiring $1 million commercial general liability and $1 million cyber liability insurance.